Based on the Zhaoke Ophthalmology Limited stock forecast from 0 analysts, the average analyst target price for Zhaoke Ophthalmology Limited is not available over the next 12 months. Zhaoke Ophthalmology Limited’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Zhaoke Ophthalmology Limited is Bearish, which is based on 2 positive signals and 6 negative signals. At the last closing, Zhaoke Ophthalmology Limited’s stock price was HKD 1.29. Zhaoke Ophthalmology Limited’s stock price has changed by -3.73% over the past week, -5.84% over the past month and -67.42% over the last year.
No recent analyst target price found for Zhaoke Ophthalmology Limited
No recent average analyst rating found for Zhaoke Ophthalmology Limited
Company Overview Zhaoke Ophthalmology Limited
Zhaoke Ophthalmology Limited, an ophthalmic pharmaceutical company, engages in the research, development, manufacture, and commercialization of therapies that address unmet medical needs in the People's Republic of China, South Korea, and Hong Kong. It is developing various drugs that cover ophthalmic indications, including dry eye diseases, wet age-related macular degeneration, diabetic macular edema, myopia, and glaucoma. The company was formerly known as China Ophthalmology Focus Limited. Zhaoke Ophthalmology Limited was incorporated in 2017 and is headquartered in Guangzhou, the People's Republic of China. Read Less
Zhaoke Ophthalmology Limited, an ophthalmic pharmaceutical company, engages in the research, development, manufacture, and commercialization of therapies that address unmet medical needs in the People's Republic of China, South Korea, and Hong Kong. It is developing various drugs...Read More
Frequently Asked Questions About Zhaoke Ophthalmology Limited (6622:HK) Stock
Stock Target Advisor's fundamental analysis for Zhaoke Ophthalmology Limited's stock is Bearish.
Unfortunately we do not have enough data on 6622:HK's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 6622:HK's stock to indicate what its average analyst target is.
6622:HK stock's Price/Earning ratio is 2.17.
Our analysis grades 6622:HK stock's Price / Earning ratio at D+. This means that 6622:HK stock's Price/Earning ratio is above 32.99999999999999% of the stocks in the Biotechnology sector in the HK exchange.
Based on this 6622:HK may be fairly valued for its sector
The last closing price of 6622:HK's stock was HKD 1.29.
The most recent market capitalization for 6622:HK is HKD 0.73B.
Unfortunately we do not have enough analyst data on 6622:HK's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Zhaoke Ophthalmology Limited's stock.
As per our most recent records Zhaoke Ophthalmology Limited has 297 Employees.
Zhaoke Ophthalmology Limited's registered address is No. 1 Meide 3rd Road, Guangzhou, China.
You can get more information about it from Zhaoke Ophthalmology Limited's website at https://www.zkoph.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Zhaoke Ophthalmology Limited (6622:HK) Stock
Stock Target Advisor's fundamental analysis for Zhaoke Ophthalmology Limited's stock is Bearish.
Unfortunately we do not have enough data on 6622:HK's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 6622:HK's stock to indicate what its average analyst target is.
6622:HK stock's Price/Earning ratio is 2.17.
Our analysis grades 6622:HK stock's Price / Earning ratio at D+. This means that 6622:HK stock's Price/Earning ratio is above 32.99999999999999% of the stocks in the Biotechnology sector in the HK exchange.
Based on this 6622:HK may be fairly valued for its sector
The last closing price of 6622:HK's stock was HKD 1.29.
The most recent market capitalization for 6622:HK is HKD 0.73B.
Unfortunately we do not have enough analyst data on 6622:HK's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Zhaoke Ophthalmology Limited's stock.
As per our most recent records Zhaoke Ophthalmology Limited has 297 Employees.
Zhaoke Ophthalmology Limited's registered address is No. 1 Meide 3rd Road, Guangzhou, China.
You can get more information about it from Zhaoke Ophthalmology Limited's website at https://www.zkoph.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 6622:HK !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
